440 Mg Trastuzumab Injection

Name: 440 Mg Trastuzumab Injection
Brand: NEETCO BIOPHARMA
Price: 20000 INR
Availability: InStock

Price 20000 INR/ Box

Get a Price/Quote

MOQ : 1 Box

440 Mg Trastuzumab Injection Specification

Salt Composition
Trastuzumab 440 mg

Dosage Form
Lyophilized Powder for Injection

Indication
Breast cancer, Gastric cancer, HER2-positive cancers

Feature
Monoclonal antibody therapy for HER2-positive cancers

Ingredients
Trastuzumab, excipients

Application
Intravenous use only

Ph Level
6.0 0.2

Physical Color/Texture
White to pale yellow powder

Fermentation Smell
Odorless

Storage Instructions
Store at 2C to 8C. Do not freeze.

Shelf Life
24 Months

Drug Type
Biosimilar/Reference Biologic

Warning
For hospital use only; cardiac monitoring required

Solubility After Reconstitution
Clear to opalescent, colorless to pale yellow solution

Route of Administration
Intravenous infusion

Reconstitution Instructions
Reconstitute with provided sterile water for injection

Pack Size
1 Vial (440 mg) with 1 vial of 20 ml sterile water for injection

Therapeutic Class
Antineoplastic (targeted therapy)

Regulatory Approval
WHO-GMP, DCGI approved

Patient Age Group
Adult

Strength
440 mg per vial

Molecular Formula
C6470H10012N1726O2013S42

Inactive Ingredients
L-histidine, polysorbate 20, sucrose

Contraindication
Hypersensitivity to trastuzumab or any excipients

Type of Packaging
Single-use glass vial

Marketed By
According to label (varies)

Dosage Frequency
As directed by oncologist

Prescription/OTC Status
Prescription only

Box Contents
Powder vial, solvent vial, leaflet

About 440 Mg Trastuzumab Injection

Order the trending 440 mg Trastuzumab Injection-a matchless monoclonal antibody therapy decorated with WHO-GMP and DCGI approvals. Each package includes a single-use glass vial containing white to pale yellow lyophilized powder and a vial of 20 ml sterile water for injection. Designed for enlightened hospital use, this product provides targeted therapy for HER2-positive breast and gastric cancers. Reconstitute as instructed and administer via intravenous infusion, ensuring cardiac monitoring. Strictly prescription-only, storing at 2C to 8C helps preserve stability. With markdown pricing available for qualified distributors, this biosimilar/reference biologic underlines therapeutic excellence.

Applications and Usage of 440 Mg Trastuzumab Injection

The 440 mg Trastuzumab Injection is primarily utilized in treating HER2-positive cancers, such as breast and gastric cancer, in adults. Decorated for its efficacy as an antineoplastic agent, it is prescribed as a targeted therapy and administered intravenously. This product is also suited for combination with chemotherapy as directed by an oncologist. Its matchless effectiveness makes it a top choice for oncological regimes requiring biosimilar monoclonal antibody use.

Payment Terms, Dispatch, and Market Coverage

We offer flexible payment terms with options to place orders at a competitive list price for single or bulk requirements. Products are dispatched promptly through reliable logistics partners to ensure delivery across all major domestic markets in India. Samples can be requested for regulated hospital use, providing a practical opportunity for evaluation before large-scale orders. Our logistics solutions are streamlined for hassle-free procurement, allowing distributors, exporters, and traders to benefit efficiently.

FAQ's of 440 Mg Trastuzumab Injection:

Q: How should the 440 mg Trastuzumab Injection be reconstituted before administration?

A: The vial must be reconstituted with the supplied 20 ml sterile water for injection as per the leaflet instructions. After proper mixing, the solution should be clear to opalescent before intravenous infusion.

Q: What are the main benefits of using 440 mg Trastuzumab Injection in cancer therapy?

A: Trastuzumab offers targeted therapy for HER2-positive breast and gastric cancers, providing matchless efficacy in slowing tumor growth and improving patient outcomes compared to traditional treatments.

Q: When is cardiac monitoring required with Trastuzumab administration?

A: Cardiac monitoring is required during and after infusion due to the risk of adverse cardiac events, especially in patients with previous heart conditions or concurrent chemotherapy use.

Q: Where is the 440 mg Trastuzumab Injection typically administered?

A: This medication is administered in a hospital or clinical setting, under the supervision of trained oncology healthcare professionals, and is strictly for prescription use only.

Q: What precautions must be taken regarding storage of this product?

A: The injection should be stored between 2C to 8C and must never be frozen. Adhering to these storage instructions maintains its stability and efficacy.

Tell us about your requirement